Related factors of chronic hepatitis B patients with suboptimal virological response to adefovir dipivoxil monotherapy and discussion for optimal therapy

LI Xiang-yong,LIN Guo-li,WU Yuan-kai,YANG Liu-qing,ZHANG Xiu-juan,LU Cui-rong,XIE Dong-ying,GAO Zhi-liang,CHONG Yu-tian

DOI: https://doi.org/10.3877/cma.j.issn.1674-1358.2011.02.005

2011-01-01

Abstract:Objective To identify the high risk factors of chronic hepatitis B patients with suboptimal virological response to adefovir dipivoxil(ADV)monotherapy,and analyze the efficacy of optimal therapy.Methods Suboptimal virological response to ADV monotherapy was defined that the serum HBV DNA level was more than 1 log_10 decline of viremia compared to baseline but still detectable(HBV DNA≥103 copies/ml)at the 48th week.All 147 patients who received ADV monotherapy for various periods were analyzed,retrospecetively.The univariate and multivariate Logistic regression model were applied for high risk factors analysis.For patients with these high risk factors,the rate of virological response(HBV DNA< 103 copies/ml)was compared between patients with or without optimal therapy by the Log-rank test.Results The univariate and multivariate Logistic regression model identified suboptimal virological response to ADV monotherapy correlated positively with LMV-resistance,state of HBeAg,baseline HBV DNA levels,primary virological non-response,initial virological response to ADV monotherapy.During subgroup analysis,the Log-rank test revealed that the virological response rate in patients with high risk factors(LMV-resistance,baseline HBeAg-positive,high baseline HBV DNA level,primary virological response and initial virological non-response to ADV monotherapy)treated with optimal therapy were higher than that of patients without optimal therapy.Conclusions LMV-resistance,baseline HBeAg positive,high baseline HBV DNA level,primary virological response and initial virological non-response to ADV monotherapy were risk factors of suboptimal viological response to ADV monotherapy.Furthermore,patients with these 5 high risk factors may benefit from optimal therapy.